Award recognizes Acurian’s delivery of superior results and service to Eli Lilly and Company
INDIANAPOLIS--(BUSINESS WIRE)-- Acurian, Inc., a leading, full-service provider of global patient recruitment and retention solutions, was selected by Eli Lilly and Company for their 2010 Lilly Global Supplier Award. The award was presented to Acurian executives in a ceremony at the company's headquarters in Indianapolis on April 12.
The Lilly Global Supplier Award recognizes suppliers who have worked collaboratively to deliver a positive and measurable impact on Lilly’s corporate objectives and priorities. The annual award is given to suppliers who exemplify the delivery of quality, service, speed, total cost reduction, and value.
“We are deeply honored and proud to receive this award from our valued customer,” said Acurian CEO Rick Malcolm. “This award recognizes our company’s outstanding and talented employees who consistently strive to make Acurian the global standard in efficiency, predictability, and performance.”
Acurian is a leading full-service provider of clinical trial patient recruitment and retention solutions for the life sciences industry. Through its proprietary patient panel of over 65 million patients, centralized advertising capabilities, and a fully hosted enrollment management technology platform, Acurian is able to identify, contact, prescreen, and refer patients into clinical trials across the globe, all while supporting investigator sites with services to maximize the randomization potential of every referred patient. Since 1998, Acurian has supported over 400 protocols for more than 60 companies. Acurian's investors include Euclid SR Partners, ProQuest Investments, JP Morgan Partners, Flatiron Partners, CDP Capital Technology Ventures, and Merck Capital Ventures.
For more information
Scott Connor, Vice President, Marketing
KEYWORDS: United States North America Indiana Pennsylvania
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Medical Devices Pharmaceutical Research Science